SCHEMBL31586908

SCHEMBL31586908

Cc1nc2ccc(Br)nc2n1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.50
▸ CDK9 P50750 5/20 0.50
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ DYRK2 Q92630 4/20 0.34
▸ PDE10A Q9Y233 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ DPP4 P27487 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HCAR1 Q9BXC0 1/20 0.31
▸ ESRRA P11474 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ CSNK1E P49674 1/20 0.30
▸ CLK1 P49759 1/20 0.30
▸ CLK2 P49760 1/20 0.30
▸ CLK3 P49761 1/20 0.30
▸ GSK3B P49841 1/20 0.30
▸ CDK5 Q00535 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12912282 0.79 CDK9 (0.53) DYRK1ACDK9KDM4EALDH1A1LMNA
SCHEMBL12891208 0.77 DYRK1A (0.47) DYRK1ACDK9KDM4EALDH1A1LMNA
SCHEMBL18335769 0.74 PARG (0.39) DYRK1ACDK9KDM4EALDH1A1LMNA
SCHEMBL20508610 0.74 DYRK1A (0.58) DYRK1ACDK9ALDH1A1DYRK2MAPT
SCHEMBL20508457 0.73 DYRK1A (0.56) DYRK1ACDK9KDM4EALDH1A1DYRK2
SCHEMBL20508516 0.72 CDK9 (0.40) DYRK1ACDK9DYRK2CSNK1ECLK1
SCHEMBL31721265 0.71 CDK9 (0.45) DYRK1ACDK9KDM4EALDH1A1LMNA
SCHEMBL20508498 0.70 CNR2 (0.41) DYRK1ACDK9DYRK2
SCHEMBL20449069 0.70 DYRK1A (0.47) DYRK1ACDK9LMNADYRK2MAPT
SCHEMBL30917272 0.69 CDK9 (0.48) DYRK1ACDK9KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106949-A1 WRN INHIBITORS RADD PHARMACEUTICALS, INC. (US) 2025-05-22 — — WO disclosed
Send feedback